Conference - Events
Featured Events
Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond. From pioneering the next generation of CAR-M therapies to unveiling novel targets, this field is on a mission to learn from the past and spearhead pipelines into clinical development.
With that, the 6th Macrophage-Directed Therapies Summit will return to Boston this year, uniting 60+ biopharma and academia leaders across R and D, Discovery, Biology, Translational, and Clinical Development fields. As a uniquely positioned platform, this event is perfect for those committed to reigniting excitement in macrophage pipeline advancement.
This is your chance to gain exclusive insig…
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
The 4th iPSC Drug Development and Manufacturing Summit is your longest standing and definitive iPSC focused industry platform showcasing cutting-edge advances across R and D through to manufacturing and analytical development to help you stay at the forefront of the iPSC cell therapy revolution.
With content split across our Research and Development and Manufacturing and Analytical Development tracks, this is the one-stop shop meeting for drug developers and academic thought leaders looking to streamline their route to the clinic and scale up their manufacturing p…
Events
With cutting-edge strategies and industry insights, the 2nd ADC Process Development Summit is back with a mission to boost conjugation yield, optimize purification, and streamline production to meet regulatory standards all whilst minimizing costs and timelines.
Join AstraZeneca, Bristol Myers Squibb, Pfizer and a community of industry experts in process development, conjugation, purification, control, CMC, and engineering. With a focused discussion on process development challenges, innovative solutions and practical takeaways, leave equipped with the technical knowledge and connections to revolutionize your ADC manufacturing process.
This Summit is a must attend for everyone looking to increase conjugation yield and enhance TFF, implement rigorous control strategies for superior drug sub…
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event. Join us at the 6th Exosome-Based Therapeutics Development Summit in September to delve into groundbreaking advancements, access exclusive clinical data, and forge pivotal partnerships to define the future of exosome drug development.
Spanning the complete development cycle of exosome therapeutics from discovery through IND filing, our summit uniquely integrates cutting-edge research with practical commercialization s…
In order to sustain a competitive advantage the manufacturers of generic drugs, biologics, biosimilars and non-branded drugs need to innovate their business models, deal structures and organizations with new ways to research, develop, formulate, commercialize and sell their products. Attending this premier marcus evans conference will permit attendees the chance to review successful alliances, innovation, partnerships, M&A activity, and portfolios at the right size, price, and mix of complexity to sustain value optimization in a domestic and international market.
19-Sep-2024 - 21-Sep-2024
Magnus Group gladly invites you to attend in person or virtually in the “11th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems” (PDDS 2024) which will take place in Rome, Italy, on September 19-21, 2024.
The subject for this global Conference is " Advancements in Pharmaceutics: Navigating the Future of Drug Delivery ".The most recent and ongoing innovations in the pharmaceutical sector will be the main subjects of discussion at Pharma Conferences in 2024. Through a range of cutting-edge methods, the pharmaceutical industry has advanced the development of new drugs. Pharmaceutical Conference will bring together scientists, researchers, students, and pharmacologists to debate this innovative invention. Pharma Congress aims to bring together distinguished speakers and p…
EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.The 24th EuroQSAR Symposium, entitled "Synergizing AI and Multiscale Modeling for Drug Discovery", is organised on behalf of QCMS and is chaired by Jordi Mestres (University of Girona).
The symposium will focus on:
Artificial Intelligence in Drug Discovery
Generative Models
Hansch & Fujita Awards
Multiscale Modelling
New Drug Modalities
New Trends in Molecular Dynamics
Protein Design
QSAR without Borders
Synthetic Data
Target-Oriented Drug Discovery
The Challenges Ahead
Translational Safety
Ultra-Large Chemical Spaces
The scientific program of the Symposium will include 9 plenary lec…
The Women's Health Innovation Summit builds the roadmap to success by uniting the entire ecosystem of stakeholders and key opinion leaders to facilitate connections, share cutting-edge knowledge, and provide a platform for deep market expertise to flourish. Our purpose is simple: to take women's health to the next level.
Our agenda is created to maximize opportunities to meet new partners at the event and to showcase the most exciting startups in the space.
Women's health is no longer just a mission, it's a business opportunity. Explore the WHIS experience to find out how we bring the community together to facilitate growth.
URLs:Tickets: https://go.evvnt.com/2369683-0?pid=185LinkedIn: https://go.evvnt.com/2369683-2?pid=185
Prices:NPO/ CHARITY/ GOVERNMENT/ CLINICIAN RATE (e…
The clinical potential of radiopharmaceuticals is huge and with continued multi-billion-dollar investments from pharmaceutical giants such as Novartis, AstraZeneca, BMS and Eli Lilly, advancing your radiopharmaceutical manufacturing processes to keep up with the pace of innovation and ensure trials can progress is crucial.
The 2nd Targeted Radiopharmaceuticals Supply Chain and Manufacturing summit returns as the only industry driven forum dedicated to advancing your radiopharmaceutical production to build reliable supply of products and accelerate trials.
Discover how to streamline your production capabilities and create a stringent supply chain network through uncovering key topics such as, isotope production, radiolabelling, quality control, regulatory considerations and supply network l…
Join us at the inaugural Novel Targeting Moiety and Payload Conjugate Summit Europe, the premier event for Europe's burgeoning novel drug conjugate market. With more companies than ever before utilising novel targeting moieties and novel payloads to widen the therapeutic index of their conjugate, this meeting will act as your gateway to explore how design approaches range from peptide-drug conjugates, bispecific-drug conjugates, antibody-oligonucleotide conjugates, radio-conjugates, and fragment drug conjugates.
Learn how alterations in the targeting moiety and payload can enhance target specificity and reduce off-target toxicity, improve tumour penetration in solid tumours, prevail over oligonucleotide delivery challenges, and improve PK properties to maximise efficacy and reduce toxicity…
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance. However, treating patients with RAS mutant cancers remains no easy feat, as knowledge gaps persist in improving the depth and durability of response, tackling emerging resistance mechanisms and informing combination strategies to improve the standard-of care for patients in need.
Owing to this, the 6th Annual RAS-Targeted Drug Development Summit returns as the central hub dedicated to every aspect of discovery and development of RAS, fro…
With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging investment has reinvigorated the space with new targets, mechanisms, and technologies to transform the mental health treatment landscape.
Capitalizing on a new wave of pipeline momentum, the 7th Neuropsychiatric Drug Development Summit returns as the industry's premier gathering, showcasing the latest circuit-based target innovation, EEG and digital biomarker data, in vivo and in vitro model advances, pioneering precision psychiatry approaches and more.
Join discovery, preclinical, translational, clinical, regulatory, and commercial experts from Karuna, Janssen, AbbVie, Otsuka, Sage Therapeutics, Lykos, Lundbeck, Compass, Biogen, Delix Therapeutic…
The spotlight continues to shine on lipid nanoparticles as the 'go-to' delivery vehicle, however the demand remains to translate learnings from vaccine LNP-mRNA success into therapeutic applications. Positioned as a delivery vehicle with no ceiling to innovation, drug developers across the field are continuing to progress research to target the previously unreachable and treating the undruggable. Pinpoint the lipid components and structural complexities, advance formulative strategy and streamline manufacture to revolutionise your LNP design.
The 3rd Lipid Nanoparticles Development Summit Europe is your premier forum to collaborate with a carefully curated community of experts across Discovery, Characterisation, Translatability, Formulation, Biodistribution, Manufacturing and much more. Th…
25-Sep-2024 - 27-Sep-2024
The marcus evans 15th Edition Next Generation Biotherapeutics Formulation, Process Development & Delivery Forum conference taking place in Cologne, Germany on 25-27 September, 2024 will explore new innovation and challenges in protein formulation for novel modalities targeting stability, high concentration, aggregation, and immunogenicity, impacting drugs like monoclonal antibodies, biospecifics, peptides, ADCs, AAV, and DNA/RNA-based therapies. We’ll discuss the design, scale up and CMC strategies using predictive, AI/ML tools to optimise formulation and delivery within complex interactions, improving lab efficiency through automation and mitigate risks and predictions. We’ll look at end to end process optimisation to maintain quality of product, while enhancing stability during deliv…
30-Sep-2024 - 01-Oct-2024
We are happy to announce the upcoming Lambda Research Group’s International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
We are happy to announce the upcoming Lambda Research Group’s International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
“We are happy to announce the upcoming Lambda Research Group’s International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine during 30 Sep 2024 - 01 Oct 2024 at London, UK.
For more about our event, visit: https://lambdaconferences.com/physiotherapy/
The conference aims to bring together students, physiotherapists, sports medicine professionals, medical faculty and researchers with the aim of exploring the latest developments in the field of physical therapy and sports medicine. The conference focuses on topics such as exercise science, injury prevention, physiologists, kinesiologists, physical therapists, athlete trainers, rehabilitation and nutrition. The unique event includes keynote lectures, panel discussions, workshops, and plenty of opportunity for b…
30-Sep-2024 - 01-Oct-2024
“We are happy to announce the upcoming Lambda Research Group’s International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, UK.
For more about our event, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
We are happy to announce the upcoming Lambda Research Group’s International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
“We are happy to announce the upcoming Lambda Research Group’s International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine during 30 Sep 2024 - 01 Oct 2024 at London, UK.
For more about our event, visit: https://lambdaconferences.com/physiotherapy/
The conference aims to bring together students, physiotherapists, sports medicine professionals, medical faculty and researchers with the aim of exploring the latest developments in the field of physical therapy and sports medicine. The conference focuses on topics such as exercise science, injury prevention, physiologists, kinesiologists, physical therapists, athlete trainers, rehabilitation and nutrition. The unique event includes keynote lectures, panel discussions, workshops, and plenty of opportunity for b…
Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond. From pioneering the next generation of CAR-M therapies to unveiling novel targets, this field is on a mission to learn from the past and spearhead pipelines into clinical development.
With that, the 6th Macrophage-Directed Therapies Summit will return to Boston this year, uniting 60+ biopharma and academia leaders across R and D, Discovery, Biology, Translational, and Clinical Development fields. As a uniquely positioned platform, this event is perfect for those committed to reigniting excitement in macrophage pipeline advancement.
This is your chance to gain exclusive insig…
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
The 4th iPSC Drug Development and Manufacturing Summit is your longest standing and definitive iPSC focused industry platform showcasing cutting-edge advances across R and D through to manufacturing and analytical development to help you stay at the forefront of the iPSC cell therapy revolution.
With content split across our Research and Development and Manufacturing and Analytical Development tracks, this is the one-stop shop meeting for drug developers and academic thought leaders looking to streamline their route to the clinic and scale up their manufacturing p…
